Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 13, 2023 08:00 ET | Source: NKGen Biotech, Inc.

NKGen Biotech to Present at the 2nd International Alzheimer’s Disease & Dementia Conference 2023

SANTA ANA, Calif., June 13, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (“NKGen”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous,...
June 05, 2023 08:00 ET | Source: NKGen Biotech, Inc.

NKGen Biotech Announces SNK01 Preclinical and Phase I/IIa Clinical Data Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

SANTA ANA, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (NKGen), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous,...
May 25, 2023 13:05 ET | Source: NKGen Biotech, Inc.

NKGen Announces Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

SANTA ANA, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (“NKGen”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous,...
June 21, 2022 08:00 ET | Source: NKGen Biotech, Inc.

NKGen Biotech to Participate in Truist Securities Cell Therapy Symposium

SANTA ANA, Calif., June 21, 2022 (GLOBE NEWSWIRE) -- NKGen Biotech, a biotechnology company harnessing the power of the body’s immune system through the development of Natural Killer (NK) cell...
May 26, 2022 17:00 ET | Source: NKGen Biotech, Inc.

NKGen Biotech To Present SNK01 Clinical Data at the 2022 ASCO Annual Meeting

SANTA ANA, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- NKGen Biotech Inc., a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell...
May 05, 2022 08:00 ET | Source: NKGen Biotech, Inc.

NKGen Biotech to Present at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting

SANTA ANA, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- NKGen Biotech Inc., a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell...
May 02, 2022 08:00 ET | Source: NKGen Biotech, Inc.

NKGen Biotech Announces Three SNK01 Abstracts to be Presented at the 2022 ASCO Annual Meeting

SANTA ANA, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- NKGen Biotech Inc., a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell...
November 15, 2021 08:00 ET | Source: NKGen Biotech, Inc.

NKGen Biotech Announces Positive SNK01 Clinical Trial Results Presented at the Society for Immunotherapy of Cancer (SITC) 2021 Annual Meeting

SANTA ANA, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- NKGen Biotech, a subsidiary of NKMax, harnessing the power of the body's immune system through the development of Natural Killer (NK) cell...
October 20, 2021 08:00 ET | Source: NKGen Biotech, Inc.

NKGen Biotech Announces Acceptance of SNK01 Abstract for Presentation at the 2021 Connective Tissue Oncology Society Annual Meeting

SANTA ANA, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- NKGen Biotech, a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell...
October 07, 2021 08:00 ET | Source: NKGen Biotech, Inc.

NKGen Biotech to Participate in the Virtual Solebury Trout Fall Private Company Showcase Co-hosted with BMO

SANTA ANA, Calif., Oct. 07, 2021 (GLOBE NEWSWIRE) -- NKGen Biotech, a biotechnology company harnessing the power of the body’s immune system through the development of Natural Killer (NK) cell...